C
Chandra Bhagat Pharma Ltd
BSE:542934
Chandra Bhagat Pharma Ltd
BSE:542934
Price:
37
INR
8.35%
Market Closed
Market Cap:
₹279.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Chandra Bhagat Pharma Ltd
BSE:542934
|
IN |
|
Liveramp Holdings Inc
NYSE:RAMP
|
US |
|
V
|
Vanov Holdings Company Ltd
HKEX:2260
|
CN |
|
A
|
Anhui Xinke New Materials Co Ltd
SSE:600255
|
CN |
|
O
|
Olympia Industries Bhd
KLSE:OLYMPIA
|
MY |
|
Deutsche EuroShop AG
XETRA:DEQ
|
DE |
|
Vineet Laboratories Ltd
NSE:VINEETLAB
|
IN |
|
Summerway Capital PLC
LSE:SWC
|
UK |
|
Japan Real Estate Investment Corp
TSE:8952
|
JP |
Income Statement
Earnings Waterfall
Chandra Bhagat Pharma Ltd
Chandra Bhagat Pharma Ltd
Income Statement
Chandra Bhagat Pharma Ltd
Chandra Bhagat Pharma Ltd
Currency: INR
| Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Interest Expense |
28
|
0
|
21
|
0
|
13
|
0
|
|
| Revenue |
941
N/A
|
952
+1%
|
1 197
+26%
|
1 947
+63%
|
2 214
+14%
|
1 670
-25%
|
|
| Gross Profit | |||||||
| Cost of Revenue |
(814)
|
(858)
|
(1 066)
|
(1 840)
|
(2 080)
|
(1 462)
|
|
| Gross Profit |
127
N/A
|
94
-26%
|
131
+39%
|
106
-19%
|
133
+25%
|
208
+56%
|
|
| Operating Income | |||||||
| Operating Expenses |
(101)
|
(74)
|
(99)
|
(140)
|
(209)
|
(247)
|
|
| Selling, General & Administrative |
(17)
|
(17)
|
(16)
|
(18)
|
(27)
|
(28)
|
|
| Research & Development |
0
|
0
|
(1)
|
0
|
(1)
|
0
|
|
| Depreciation & Amortization |
(0)
|
(1)
|
(1)
|
(6)
|
(5)
|
(6)
|
|
| Other Operating Expenses |
(83)
|
(56)
|
(82)
|
(115)
|
(177)
|
(212)
|
|
| Operating Income |
26
N/A
|
20
-25%
|
31
+60%
|
(34)
N/A
|
(76)
-127%
|
(39)
+49%
|
|
| Pre-Tax Income | |||||||
| Interest Income Expense |
(28)
|
(27)
|
(22)
|
(18)
|
(13)
|
(16)
|
|
| Non-Reccuring Items |
(1)
|
0
|
(1)
|
0
|
(1)
|
0
|
|
| Total Other Income |
14
|
18
|
3
|
67
|
112
|
74
|
|
| Pre-Tax Income |
11
N/A
|
11
-4%
|
12
+10%
|
15
+33%
|
23
+46%
|
20
-14%
|
|
| Net Income | |||||||
| Tax Provision |
(3)
|
(3)
|
(3)
|
(4)
|
(7)
|
(4)
|
|
| Income from Continuing Operations |
8
|
7
|
9
|
12
|
15
|
16
|
|
| Net Income (Common) |
8
N/A
|
7
-8%
|
9
+24%
|
12
+29%
|
15
+31%
|
16
+3%
|
|
| EPS (Diluted) |
1.06
N/A
|
0.98
-8%
|
1.2
+22%
|
1.55
+29%
|
2.03
+31%
|
2.1
+3%
|
|
Switch to:
Switch to:
See Also
Discover More
